Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons | The BMJ
Aspirin and an oral anticoagulant – can they be used together? - NPS MedicineWise
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials -
RBCP - Cost comparison between enoxaparin and new oral anticoagulants dabigatran and rivaroxaban in venous thromboembolism prophylaxis
Pharmacokinetic and pharmacodynamic evaluation of rivaroxaban: considerations for the treatment of venous thromboembolism | Thrombosis Journal | Full Text
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association
Rivaroxaban: a fully-subsidised oral anticoagulant
Cureus | Current Trends in the Duration of Anticoagulant Therapy for Venous Thromboembolism: A Systematic Review
Transition of Anticoagulants 2016
Direct Oral Anticoagulants: A User's Guide | Consultant360
Xarelto® - Responsible Use
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial - The Lancet
Safety Profile - DVT & PE Initial Treatment | XARELTO® (rivaroxaban) HCP
Guidance on converting between anticoagulants
Guideline for the Prescribing of Novel Oral Anticoagulants (NOACs): Dabigatran (Pradaxa ), Rivaroxaban (Xarelto ), Apixaban (Eliquis ) - PDF Free Download
![PDF] Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c3bd71fdf61b8f8bdc9321c5d380254016ae03ea/20-Table1-1.png "PDF] Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery | Semantic Scholar")
PDF] Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery | Semantic Scholar
Updated Guidelines on Outpatient Anticoagulation | AAFP
Antithrombotic Management of Venous Thromboembolism: JACC Focus Seminar - ScienceDirect
Xarelto® Rivaroxaban The first oral direct factor Xa inhibitor - ppt download
How to switch from rivaroxaban to LMWH? | Download Scientific Diagram
Transition of Anticoagulants 2014
Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology | Revista Española de Cardiología
Oral anticoagulants in the management of venous thromboembolism | Nature Reviews Cardiology
Bridging the Gap: How to Transition from the NOACs to Warfarin - PDF Free Download
How to switch from rivaroxaban to LMWH? | Download Scientific Diagram
Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons | The BMJ
Time for a change? Switching anticoagulants in patients with AF or VTE | Thrombosis Adviser
